Fungicidal activity of a phospholipase A2-derived synthetic peptide variant against Candida albicans

Revista Espanola de Quimioterapia

Volumn 20, Issue 3, 2007, Pages 330-333

  Murillo, Luis A ^a   Lan, Chung Yu ^a   Agabian, Nina M ^a   Larios, Silda ^b   Lomonte, Bruno ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Universidad Nacional Autonoma de Nicaragua   (Nicaragua)

^c UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

Candida; Fungicidal; Microbicidal; Phospholipase A 2; Synthetic peptide

Indexed keywords

LYSYLLYSYLTRYPTOPHYLARGINYLTRYPTOPHYLTRYPTOPHYLLEUCYLLYSYLALANYL LEUCYLALANYLLYSYLLYSINE; PEPTIDE DERIVATIVE; PHOSPHOLIPASE A2; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG PENETRATION; FUNGICIDAL ACTIVITY; HEMOLYSIS; NONHUMAN; PEPTIDE SYNTHESIS;

ANIMALS; ANTIFUNGAL AGENTS; BOTHROPS; CALCIUM; CANDIDA ALBICANS; CELL MEMBRANE PERMEABILITY; CROTALID VENOMS; GROUP II PHOSPHOLIPASES A2; MAGNESIUM; PEPTIDE FRAGMENTS; REPTILIAN PROTEINS;

EID: 36949017087     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Marchetti, O., Bille, J., Fluckiger, U. et al. Epidemiology of candidemia in Swiss tertiary care hospitals: Secular trends, 1991-2000. Clin Infect Dis 2004; 38: 311-320.
2. Marr, K.A. The changing spectrum of candidemia in oncology patients: Therapeutic implications. Curr Opin Infect Dis 2000; 13: 615-620.
3. Corpus, K., Hegeman-Dingle, R., Bajjoka, I. Candida kefyr, an uncommon but emerging fungal pathogen: Report of two cases. Pharmacotherapy 2004; 24: 1084-1088.
4. Situ, H., Bobek, L.A. In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1. Antimicrob Agents Chemother 2000; 44: 1485-1493.
5. Nissen-Meyer, J., Nes, I.F. Ribosomally synthesized antimicrobial peptides: Their function, structure, biogenesis, and mechanism of action. Arch Microbiol 1997; 167: 67-77.
6. Lee, D.G., Kim, H.K., Kim, S.A. et al. Fungicidal effect of indolicidin and its interaction with phospholipid membranes. Biochem Biophys Res Commun 2003; 305: 305-310.
7. Heimerhorst, E.J., Reijnders, I.M., Van't Hof, W., Veerman, E.C., Nieuw, A.V. A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides. FEBS Lett 1999; 449: 105-110.
8. Nikawa, H., Fukushima, H., Makihira, S., Hamada, T., Samaranayake, L.P. Fungicidal effect of three new synthetic cationic peptides against Candida albicans. Oral Dis 2004; 10: 221-228.
9. Nikawa, H., Jin, C., Fukushima, H., Makihira, S., Hamada, T. Antifungal activity of histatin-5 against non-albicans Candida species. Oral Microbiol Immunol 2001; 16: 250-252.
10. Solórzano, A. Serpientes de Costa Rica. Editorial InBio, Costa Rica 2004.
11. 2 myotoxins from crotalid snake venoms and their structural determinants of myotoxic action. Toxicon 2003; 42: 885-901.
12. 2 from Bothrops asper snake venom: Synthetic Lys49 myotoxin II-(115-129)-peptide identifies its bactericidal region. Eur J Biochem 1998; 253: 452-461.
13. 2 from crotalid snake venoms and synthetic peptide variants derived from their C-terminal region. Toxicon 2005; 45: 807-815.
14. 2. Antimicrob Agents Chemother 2005; 49: 1340-1345.
15. Fields, G.B., Noble, R.L. Solid-phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int J Pept Protein Res 1990; 35: 161-214.
16. Edgerton, M., Koshlukova, S.E., Lo, T.E. et al. Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans. J Biol Chem 1998; 273: 20438-20447.
17. Dong, J., Vylkova, S., Li, X.S., Edgerton, M. Calcium blocks fungicidal activity of human salivary histatin 5 through disruption of binding with Candida albicans. J Dent Res 2003; 82: 748-752.
18. Bashford, C.L., Alder, G.M., Graham, J.M., Menestrina, G., Pasternak, C. Ion modulation of membrane permeability: Effect of cations on intact cells and on cells and phospholipid bilayers treated with pore-forming agents. J Membr Biol 1988; 103: 79-94.
19. Bashford, C.L., Rodrigues, L., Pasternak, C.A. Protection of cells against membrane damage by haemolytic agents: Divalent cations and protons act at the extracellular side of the plasma membrane. Biochim Biophys Acta 1989; 983: 56-64.